A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer by Berghmans, Thierry, Scherpereel, Arnaud, Meert, Anne-Pascale, Giner, Vicente, Lecomte, Jacques, Lafitte, Jean-Jacques, Leclercq, Nathalie, Paesmans, Marianne, Sculier, Jean-Paul

Get full text

A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma by Berghmans, T., Lafitte, J.J., Paesmans, M., Stach, B., Berchier, M.C., Wackenier, P., Lecomte, J., Collon, T., Mommen, P., Sculier, J.P.

Get full text

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis by Mascaux, C., Paesmans, M., Berghmans, T., Branle, F., Lafitte, J.J., Lemaı̂tre, F., Meert, A.P., Vermylen, P., Sculier, J.P.

Get full text

Role of p53 positivity on the survival of patients with lung cancer as assessed by a systematic review of the literature by Paesmans, M, Steels, E, Berghmans, T, Branle, F, Burniat, A, Ghisdal, L, Lafitte, J.J, Lemaitre, F, Mascaux, C, Meert, A.P, Vallot, F, Sculier, J.P

Get full text

Is it a place for mitomycin C (MMC) in the treatment of non-small cell lung cancer (NSCLC)? A meta-analysis by Berghmans, T, Ghisdal, L, Paesmans, M, Branle, F, Burniat, A, Lafitte, J.J, Lemaitre, F, Mascaux, C, Meert, A.P, Steels, E, Vallot, F, Sculier, J.P

Get full text

A literature-based qualtative and quantitative overview of chemotherapy for malignant mesothelioma by Paesmans, M, Berghmans, T, Lalami, Y, Lemaĭtre, F, Louviaux, I, Luce, S, Pegrimocova, R, Vermylen, Ph, Sculier, JP, European Lung Cancer Working Party (ELCWP)

Get full text

A literature-based qualitative and quantitative overview of chemotherapy versus best supportive care for stage IV non-small cell lung cancer (NSCLC) by Paesmans, M, Berghmans, T, Castaigne, C, Lalami, Y, Luce, S, Sotiriou, C, Vermylen, Ph, Sculier, JP, European Lung Cancer Working Party (ELCWP)

Get full text

Is chemosensitivity a predictive factor for radiosensitivity in non-small cell lung cancer? Lesson from European Lung Cancer working party phase III randomised trial by Baumöhl, J, Sculier, JP, Paesmans, M, Bureau, G, Recloux, P, Van Cutsem, O, Berchier, MC, Thiriaux, J, Lafitte, JJ, Mommen, P, Van Houtte, P, Ninane, V, Klastersky, J, European Lung Cancer Working Party (ELCWP)

Get full text